Influenza inactivated quadrivalent vaccine - FORT
Alternative Names: Influenza virus vaccine - FORT LLC; Ultrix QuadriLatest Information Update: 01 Mar 2022
At a glance
- Originator FORT; Nacimbio
- Developer FORT
- Class Antivirals; Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Influenza virus infections
Most Recent Events
- 16 Feb 2022 Registered for Influenza virus infections (Prevention, In children, In adults, In the elderly, In adolescents) in Russia (Parenteral) (FORT LLC website, February 2022)
- 23 Jun 2021 Registered for Influenza virus infections (Prevention) in Turkmenistan (Parenteral)
- 17 May 2021 Registered for Influenza virus infections (Prevention) in Belarus (Parenteral)